AstraZeneca To Buy US-based Icosavax In Around $1.1 Bln Deal

British drug major AstraZeneca Plc. (AZN.L,AZN) announced Tuesday that it has entered into a definitive agreement to acquire Icosavax, Inc. (ICVX), a US-based clinical-stage biopharmaceutical company, for a transaction value of around $1.1 billion. Under the deal terms, AstraZeneca, through a subsidiary, will initiate a tender offer to acquire Icosavax shares for $15.00 per share in cash at closing. The […]

Read more

Roche To Acquire Carmot Therapeutics For $2.7 Bln Cash Plus Milestone Payments

Swiss drug major Roche Holding AG (RHHBY) announced Monday that it has signed a definitive merger agreement to acquire Carmot Therapeutics, Inc., a privately owned US clinical-stage biotechnology company, for $2.7 billion upfront in cash at the closing of the transaction. The deal also includes additional payments of up to $400 million depending on the achievement of certain milestones. The […]

Read more

UK Clears Microsoft's Activision Acquisition Without Cloud Gaming Rights

UK’s Competition and Markets Authority or CMA said on Friday that it has cleared the acquisition of Activision Blizzard, Inc. (ATVI) by tech giant Microsoft Corp. (MSFT) without cloud gaming rights. The decision was taken after the UK competition regulatory authority concluded that the deal would now preserve competitive prices and better services. As per the concession made by Microsoft […]

Read more

BAE Systems To Buy Ball Aerospace Business From Ball Corp. In About $5.6 Bln Cash Deal

British arms, security, and aerospace firm BAE Systems Plc (BA.L) announced Thursday its agreement to acquire Ball Aerospace business from Ball Corp. (BALL) for around $5.55 billion in cash, subject to customary closing adjustments. The proposed acquisition is expected to be earnings accretive in the first full year including run-rate cost synergies, and cashflow accretive in the first year excluding […]

Read more

DISH, EchoStar To Combine In All-stock Deal

DISH Network Corp. (DISH) and EchoStar Corp. (SATS) announced Tuesday they have entered into a definitive agreement for DISH to combine with EchoStar in an all-stock merger at a fixed exchange ratio. The transaction was negotiated and recommended by Special Committees of Independent Directors of both companies and unanimously approved by the Boards of Directors of both companies. The deal […]

Read more

Axa H1 Profit Nearly Flat, Premiums Rise; Backs FY23 View; To Buy Laya Healthcare For EUR 650 Mln

French Insurance company Axa S.A. (AXAHY.PK) reported Thursday that its first-half net income edged down to 3.833 billion euros from last year’s 3.852 billion euros. Underlying earnings grew 19 percent to 4.11 billion euros from last year’s 3.47 billion euros. Underlying earnings under IFRS4 grew 5%. Underlying earnings per share increased 8 percent to 1.79 euros from 1.65 euros in […]

Read more

Neurogene, Neoleukin Announce Planned Merger

Neurogene Inc. and Neoleukin Therapeutics, Inc. (NLTX) have entered into a definitive merger agreement in an all-stock deal. Upon closing, Neoleukin Therapeutics will be renamed Neurogene Inc. The combined company will be led by Rachel McMinn, Founder and CEO of Neurogene, and other members of the Neurogene management team. Pre-merger Neoleukin stockholders are expected to own approximately 16% of the […]

Read more
1 2 3 17